UP

British drug maker expands vaccine production deal

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto
British drug maker expands vaccine production deal

British drug manufacturer AstraZeneca has expanded its agreement with an Oxford firm to increase its production of a potential coronavirus vaccine, local media reported on Tuesday.

Axar.az reports that, the firm, Oxford Biomedica, will produce tens of millions of doses of the potential vaccine, known as AZD1222, as part of the £50 million ($66.9 million) deal.

It will do so for 18 months, with the possibility of extending it by another 18 months after that.

Production will take place in Oxford, and Astra Zeneca said its global production capacity is now close to 3 billion doses.

Date
2020.09.01 / 21:33
Author
Axar.az
See also

Stop believing these 6 common diet myths - BBC

Over 60 children infected with measles in London

WHO says low risk of Nipah virus spreading beyond India

Asian countries step up airport checks over Nipah virus

Deadly Nipah virus cases reported in India

Robots get human-like “Smart Skin”

WHO warns of rapid spread of "Hong Kong Flu"

Japanese frog bacteria kill cancer cells

Stem cell drug offers non-opioid osteoarthritis pain relief

US develops AI tool for early breast cancer detection

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla